LIN28B is over-expressed in specific subtypes of pediatric leukemia and regulates lncRNA H19.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26969084)

Published in Haematologica on March 11, 2016

Authors

Hetty H Helsmoortel1, Barbara De Moerloose2, Tim Pieters3, Farzaneh Ghazavi1, Silvia Bresolin4, Hélène Cavé5, Andrica de Vries6, Valerie de Haas7, Christian Flotho8, Veerle Labarque9, Charlotte Niemeyer8, Pascale De Paepe10, Nadine Van Roy11, Jan Stary12, Marry M van den Heuvel-Eibrink13, Yves Benoit2, Johannes Schulte14, Steven Goossens15, Geert Berx15, Jody J Haigh16, Frank Speleman11, Pieter Van Vlierberghe11, Tim Lammens17

Author Affiliations

1: Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Belgium Center for Medical Genetics, Ghent University, Belgium.
2: Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Belgium.
3: Center for Medical Genetics, Ghent University, Belgium Unit for Molecular and Cellular Oncology, VIB Inflammation Research Center, Ghent University, Belgium Department of Biomedical Molecular Biology, Ghent University, Belgium.
4: Department of Women and Child Health, University of Padova, Italy.
5: Department of Genetics, University Hospital of Robert Debré and Paris-Diderot University, Paris, France.
6: Department of Paediatric Oncology/Haematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
7: Dutch Childhood Oncology Group (DCOG), the Hague, the Netherlands.
8: Department of Paediatrics and Adolescent Medicine, Division of Paediatric Haematology and Oncology, University of Freiburg, Germany.
9: Pediatric Haemato-Oncology, University Hospitals Leuven, Belgium.
10: Pathological Anatomy, AZ Sint Jan Bruges, Belgium.
11: Center for Medical Genetics, Ghent University, Belgium.
12: Department of Paediatric Haematology/Oncology, Charles University and University Hospital Motol, Prague, Czech Republic.
13: Dutch Childhood Oncology Group (DCOG), the Hague, the Netherlands Princess Maxima Center for Paediatric Oncology, Utrecht, the Netherlands.
14: Division of Neuroblastoma Genomics, German Cancer Research Center (DKFZ), Heidelberg, Germany Department of Paediatric Oncology and Haematology, University Children's Hospital Essen, Essen, Germany German Consortium for Translational Cancer Research (DKTK), Essen, Germany Translational Neuro-Oncology, West German Cancer Center (WTZ), University Hospital Essen, University Duisburg-Essen, Germany Centre for Medical Biotechnology, University Duisburg-Essen, Germany.
15: Unit for Molecular and Cellular Oncology, VIB Inflammation Research Center, Ghent University, Belgium Department of Biomedical Molecular Biology, Ghent University, Belgium.
16: Mammalian Functional Genetics Laboratory, Division of Blood Cancers, Australian Centre for Blood Diseases, Monash University, Melbourne, Victoria, Australia.
17: Department of Paediatric Haematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Belgium Tim.Lammens@UGent.be.

Articles cited by this

GenePattern 2.0. Nat Genet (2006) 29.07

Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet (2009) 6.35

A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study. Lancet Oncol (2009) 5.22

The Lin28/let-7 axis regulates glucose metabolism. Cell (2011) 4.65

The imprinted H19 lncRNA antagonizes let-7 microRNAs. Mol Cell (2013) 3.27

Gene expression classifiers for relapse-free survival and minimal residual disease improve risk classification and outcome prediction in pediatric B-precursor acute lymphoblastic leukemia. Blood (2009) 2.86

LNCipedia: a database for annotated human lncRNA transcript sequences and structures. Nucleic Acids Res (2012) 2.40

Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants. Blood (2009) 2.19

A comprehensive transcriptional portrait of human cancer cell lines. Nat Biotechnol (2014) 2.17

Lin28b reprograms adult bone marrow hematopoietic progenitors to mediate fetal-like lymphopoiesis. Science (2012) 2.03

LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression. Nat Genet (2012) 1.96

Evaluation of gene expression signatures predictive of cytogenetic and molecular subtypes of pediatric acute myeloid leukemia. Haematologica (2010) 1.71

Genomic profiling in Down syndrome acute lymphoblastic leukemia identifies histone gene deletions associated with altered methylation profiles. Leukemia (2011) 1.67

The Lin28b-let-7-Hmga2 axis determines the higher self-renewal potential of fetal haematopoietic stem cells. Nat Cell Biol (2013) 1.67

Genome-wide signatures of differential DNA methylation in pediatric acute lymphoblastic leukemia. Genome Biol (2013) 1.57

Oncofetal H19 RNA promotes tumor metastasis. Biochim Biophys Acta (2014) 1.35

Gene expression profiles predictive of outcome and age in infant acute lymphoblastic leukemia: a Children's Oncology Group study. Blood (2011) 1.25

The H19/let-7 double-negative feedback loop contributes to glucose metabolism in muscle cells. Nucleic Acids Res (2014) 1.16

Lin28b promotes fetal B lymphopoiesis through the transcription factor Arid3a. J Exp Med (2015) 1.03

MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures. BMC Med Genomics (2009) 0.97

Elevated S100A8/S100A9 expression causes glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia. Leukemia (2012) 0.90

MLL partner genes drive distinct gene expression profiles and genomic alterations in pediatric acute myeloid leukemia: an AIEOP study. Leukemia (2011) 0.88

High expression of EVI1 and MEL1 is a compelling poor prognostic marker of pediatric AML. Leukemia (2015) 0.87

The role of Lin28b in myeloid and mast cell differentiation and mast cell malignancy. Leukemia (2015) 0.85

Efficient ROSA26-based conditional and/or inducible transgenesis using RMCE-compatible F1 hybrid mouse embryonic stem cells. Stem Cell Rev (2013) 0.83

LIN28: A Stem Cell Factor with a Key Role in Pediatric Tumor Formation. Stem Cells Dev (2016) 0.81

LIN28B overexpression defines a novel fetal-like subgroup of juvenile myelomonocytic leukemia. Blood (2015) 0.81

Gene expression profiles associated with pediatric relapsed AML. PLoS One (2015) 0.80

Gene expression signatures of pediatric myelodysplastic syndromes are associated with risk of evolution into acute myeloid leukemia. Leukemia (2012) 0.79